Brenda Mann - Net Worth and Insider Trading

Brenda Mann Net Worth

The estimated net worth of Brenda Mann is at least $116 dollars as of 2024-11-13. Brenda Mann is the VP of Research & Development of Kiora Pharmaceuticals Inc and owns about 32 shares of Kiora Pharmaceuticals Inc (KPRX) stock worth over $116. Details can be seen in Brenda Mann's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brenda Mann has not made any transactions after 2019-07-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Brenda Mann

To

Brenda Mann Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brenda Mann owns 1 companies in total, including Kiora Pharmaceuticals Inc (KPRX) .

Click here to see the complete history of Brenda Mann’s form 4 insider trades.

Insider Ownership Summary of Brenda Mann

Ticker Comapny Transaction Date Type of Owner
KPRX Kiora Pharmaceuticals Inc 2019-11-05 VP of Research & Development

Brenda Mann Latest Holdings Summary

Brenda Mann currently owns a total of 1 stock. Brenda Mann owns 32 shares of Kiora Pharmaceuticals Inc (KPRX) as of July 15, 2019, with a value of $116.

Latest Holdings of Brenda Mann

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KPRX Kiora Pharmaceuticals Inc 2019-07-15 32 3.62 116

Holding Weightings of Brenda Mann


Brenda Mann Form 4 Trading Tracker

According to the SEC Form 4 filings, Brenda Mann has made a total of 0 transactions in Kiora Pharmaceuticals Inc (KPRX) over the past 5 years. The most-recent trade in Kiora Pharmaceuticals Inc is the sale of 4 shares on July 15, 2019, which brought Brenda Mann around $4,572.

Insider Trading History of Brenda Mann

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Brenda Mann Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Brenda Mann Ownership Network

Ownership Network List of Brenda Mann

No Data

Ownership Network Relation of Brenda Mann

Insider Network Chart

Brenda Mann Owned Company Details

What does Kiora Pharmaceuticals Inc do?

Who are the key executives at Kiora Pharmaceuticals Inc?

Brenda Mann is the VP of Research & Development of Kiora Pharmaceuticals Inc. Other key executives at Kiora Pharmaceuticals Inc include EVP of Finance Melissa Tosca , Chief Development Officer Eric Joseph Daniels , and director & President and CEO Brian M. Strem .

Kiora Pharmaceuticals Inc (KPRX) Insider Trades Summary

Over the past 18 months, Brenda Mann made no insider transaction in Kiora Pharmaceuticals Inc (KPRX). Other recent insider transactions involving Kiora Pharmaceuticals Inc (KPRX) include a net purchase of 2,100 shares made by Melissa Tosca , a net purchase of 5,260 shares made by Erin Parsons , and a net purchase of 5,000 shares made by Praveen Tyle .

In summary, during the past 3 months, insiders sold 0 shares of Kiora Pharmaceuticals Inc (KPRX) in total and bought 12,500 shares, with a net purchase of 12,500 shares. During the past 18 months, 0 shares of Kiora Pharmaceuticals Inc (KPRX) were sold and 22,291 shares were bought by its insiders, resulting in a net purchase of 22,291 shares.

Kiora Pharmaceuticals Inc (KPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kiora Pharmaceuticals Inc Insider Transactions

No Available Data

Brenda Mann Mailing Address

Above is the net worth, insider trading, and ownership report for Brenda Mann. You might contact Brenda Mann via mailing address: C/o Eyegate Pharmaceuticals, Inc., 271 Waverly Oaks Road, Suite 108, Waltham Ma 02452.